Table 1 Clinical and serological characterstics of SSc patients.

From: Expression of apoptotic and proliferation factors in gastric mucosa of patients with systemic sclerosis correlates with form of the disease

Characteristic

 

Value

Age (years)a

 

54.3 ± 13.60

Gender

Female

15 (100)

SSc duration (years)b

 

13 (1–35)

SSc subset

lcSSc

5 (33.33)

dcSSc

10 (66.66)

Autoantibody pattern

ANA positivity

13 (86.66)

ACA

4 (26.66)

Anti-Scl 70

9 (60.00)

mRSSb

 

15 (4–26)

GI tract involvement

Present

10 (66.66)

Joint/tendon involvement

Present

12 (80.00)

Muscular involvement

Present

10 (66.66)

Digital ulcers

Present

3 (20.00)

Peripheral vascular involvement

Present

12 (80.00)

Interstitial lung disease

Present

8 (53.33)

DLCOa

 

58.44 ± 22.16

Heart involvement

Present

3 (20.00)

  1. aValues expressed as mean ± standard deviation. b Values expressed as median with minimum-maximum range. Values expressed as absolute number (%) unless otherwise indicated. SSc, systemic sclerosis; lcSSc, limited cutaneous systemic sclerosis; dcSSc, diffuse cutaneous systemic sclerosis; ANA, antinuclear antibodies; ACA, anticentromere antibodies; Anti-Scl 70, anti-topoisomerase I antibodies; mRSS, modified Rodnan skin score; GI, gastrointestinal; DLCO, diffusing capacity for carbon monoxide (% predicted).
Back to article page